Rank | Gene Set | Z-score |
---|---|---|
1 | neutrophil activation involved in immune response (GO:0002283) | 5.69246820 |
2 | negative regulation of interleukin-12 production (GO:0032695) | 5.43816610 |
3 | purine nucleobase biosynthetic process (GO:0009113) | 5.28316464 |
4 | response to peptidoglycan (GO:0032494) | 5.18778651 |
5 | positive regulation by symbiont of host defense response (GO:0052509) | 5.01931020 |
6 | modulation by symbiont of host defense response (GO:0052031) | 5.01931020 |
7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.01931020 |
8 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.01931020 |
9 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.01931020 |
10 | modulation by symbiont of host immune response (GO:0052553) | 5.01931020 |
11 | macrophage activation involved in immune response (GO:0002281) | 4.89031657 |
12 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.85519602 |
13 | nucleobase biosynthetic process (GO:0046112) | 4.74943245 |
14 | detection of molecule of bacterial origin (GO:0032490) | 4.74863773 |
15 | maturation of SSU-rRNA (GO:0030490) | 4.74453508 |
16 | rRNA modification (GO:0000154) | 4.73458781 |
17 | mitotic metaphase plate congression (GO:0007080) | 4.71817031 |
18 | ribosome assembly (GO:0042255) | 4.64564820 |
19 | proteasome assembly (GO:0043248) | 4.42357583 |
20 | DNA replication checkpoint (GO:0000076) | 4.42005785 |
21 | DNA deamination (GO:0045006) | 4.41180130 |
22 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 4.40778933 |
23 | termination of RNA polymerase III transcription (GO:0006386) | 4.40778933 |
24 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.30832589 |
25 | negative regulation of cell killing (GO:0031342) | 4.30832589 |
26 | detection of other organism (GO:0098543) | 4.19661265 |
27 | ribosome biogenesis (GO:0042254) | 4.11444844 |
28 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.09940614 |
29 | termination of RNA polymerase I transcription (GO:0006363) | 4.07805629 |
30 | detection of external biotic stimulus (GO:0098581) | 4.07206208 |
31 | positive regulation of mast cell activation (GO:0033005) | 4.06599491 |
32 | ribosomal large subunit biogenesis (GO:0042273) | 4.05009851 |
33 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 4.04489883 |
34 | immunoglobulin mediated immune response (GO:0016064) | 4.04221350 |
35 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.04068837 |
36 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.99936910 |
37 | regulation of mast cell degranulation (GO:0043304) | 3.98506659 |
38 | cellular extravasation (GO:0045123) | 3.94578551 |
39 | granulocyte activation (GO:0036230) | 3.94514321 |
40 | ribosomal small subunit biogenesis (GO:0042274) | 3.87191076 |
41 | ribosomal small subunit assembly (GO:0000028) | 3.86891677 |
42 | rRNA methylation (GO:0031167) | 3.86510342 |
43 | microglial cell activation (GO:0001774) | 3.86099548 |
44 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.85396632 |
45 | positive regulation of mast cell degranulation (GO:0043306) | 3.82977166 |
46 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.82977166 |
47 | neutrophil activation (GO:0042119) | 3.81763707 |
48 | 7-methylguanosine mRNA capping (GO:0006370) | 3.81270786 |
49 | macrophage activation (GO:0042116) | 3.80858556 |
50 | folic acid metabolic process (GO:0046655) | 3.78800661 |
51 | glycosphingolipid catabolic process (GO:0046479) | 3.78365492 |
52 | regulation of spindle organization (GO:0090224) | 3.77742937 |
53 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.77407381 |
54 | transcription from RNA polymerase I promoter (GO:0006360) | 3.77136937 |
55 | metaphase plate congression (GO:0051310) | 3.76145817 |
56 | detection of bacterium (GO:0016045) | 3.72854931 |
57 | 7-methylguanosine RNA capping (GO:0009452) | 3.72840202 |
58 | RNA capping (GO:0036260) | 3.72840202 |
59 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.72456219 |
60 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.70933847 |
61 | rRNA processing (GO:0006364) | 3.70285306 |
62 | CENP-A containing nucleosome assembly (GO:0034080) | 3.68173047 |
63 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.66348935 |
64 | folic acid transport (GO:0015884) | 3.64363020 |
65 | myeloid cell activation involved in immune response (GO:0002275) | 3.61245369 |
66 | rRNA metabolic process (GO:0016072) | 3.60726312 |
67 | oligosaccharide catabolic process (GO:0009313) | 3.58655642 |
68 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.58207800 |
69 | detection of biotic stimulus (GO:0009595) | 3.56270724 |
70 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.52982803 |
71 | formation of translation preinitiation complex (GO:0001731) | 3.52803921 |
72 | regulation of mast cell activation (GO:0033003) | 3.52265855 |
73 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.51906254 |
74 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.51286151 |
75 | respiratory burst (GO:0045730) | 3.47053322 |
76 | regulation of leukocyte degranulation (GO:0043300) | 3.46458428 |
77 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.46353475 |
78 | transcription initiation from RNA polymerase I promoter (GO:0006361) | 3.45831759 |
79 | T-helper 1 type immune response (GO:0042088) | 3.45009595 |
80 | chromatin remodeling at centromere (GO:0031055) | 3.44792864 |
81 | DNA replication initiation (GO:0006270) | 3.43548977 |
82 | regulation of mononuclear cell migration (GO:0071675) | 3.41094499 |
83 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.40478789 |
84 | positive regulation of leukocyte degranulation (GO:0043302) | 3.39415525 |
85 | response to host immune response (GO:0052572) | 3.39302717 |
86 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.39302717 |
87 | kinetochore assembly (GO:0051382) | 3.39207577 |
88 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.39196874 |
89 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.38359126 |
90 | glycolipid catabolic process (GO:0019377) | 3.38119535 |
91 | regulation of gamma-delta T cell activation (GO:0046643) | 3.37943375 |
92 | DNA replication-independent nucleosome organization (GO:0034724) | 3.29948360 |
93 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.29948360 |
94 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.29773384 |
95 | DNA strand elongation (GO:0022616) | 3.29762785 |
96 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.27492395 |
97 | pseudouridine synthesis (GO:0001522) | 3.23990648 |
98 | viral transcription (GO:0019083) | 3.23679590 |
99 | interferon-gamma secretion (GO:0072643) | 3.23383199 |
100 | spliceosomal snRNP assembly (GO:0000387) | 3.23358232 |
101 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.21597439 |
102 | translational termination (GO:0006415) | 3.20417727 |
103 | DNA-templated transcription, elongation (GO:0006354) | 3.19879897 |
104 | transcription elongation from RNA polymerase II promoter (GO:0006368) | 3.19753741 |
105 | positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968) | 3.18887672 |
106 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.18049910 |
107 | maturation of 5.8S rRNA (GO:0000460) | 3.17300968 |
108 | translational initiation (GO:0006413) | 3.17254400 |
109 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 3.16639456 |
110 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.15701084 |
111 | lung-associated mesenchyme development (GO:0060484) | 3.15241556 |
112 | telomere maintenance via recombination (GO:0000722) | 3.13950246 |
113 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.13560691 |
114 | blastocyst development (GO:0001824) | 3.13549584 |
115 | * amino sugar catabolic process (GO:0046348) | 3.13457984 |
116 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.12891411 |
117 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 3.09530431 |
118 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.09245212 |
119 | histone exchange (GO:0043486) | 3.08168043 |
120 | B cell mediated immunity (GO:0019724) | 3.07476678 |
121 | cellular component biogenesis (GO:0044085) | 3.07056373 |
122 | germinal center formation (GO:0002467) | 3.06161295 |
123 | establishment of chromosome localization (GO:0051303) | 3.05811551 |
124 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.04819504 |
125 | negative regulation of ligase activity (GO:0051352) | 3.03810698 |
126 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.03810698 |
127 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.03490711 |
128 | kinetochore organization (GO:0051383) | 3.01754070 |
129 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.01703099 |
130 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.01668904 |
131 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.99762921 |
132 | ceramide catabolic process (GO:0046514) | 2.98784397 |
133 | DNA-dependent DNA replication (GO:0006261) | 2.98679623 |
134 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.98541913 |
135 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.98429923 |
136 | meiosis I (GO:0007127) | 2.98378827 |
137 | positive regulation of ligase activity (GO:0051351) | 2.97485326 |
138 | regulation of interferon-alpha production (GO:0032647) | 2.96987343 |
139 | spindle checkpoint (GO:0031577) | 2.96307702 |
140 | response to host (GO:0075136) | 2.95929220 |
141 | response to host defenses (GO:0052200) | 2.95929220 |
142 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.95929220 |
143 | positive regulation of antigen processing and presentation (GO:0002579) | 2.95317205 |
144 | positive regulation of viral transcription (GO:0050434) | 2.93501679 |
145 | regulation of mitotic spindle organization (GO:0060236) | 2.91692628 |
146 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.91272582 |
147 | response to muramyl dipeptide (GO:0032495) | 2.91151158 |
148 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 2.91143479 |
149 | positive regulation of chromosome segregation (GO:0051984) | 2.90074086 |
150 | mitotic recombination (GO:0006312) | 2.89058913 |
151 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.88339864 |
152 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.88339864 |
153 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.88339864 |
154 | myeloid leukocyte activation (GO:0002274) | 2.88243372 |
155 | regulation of macrophage chemotaxis (GO:0010758) | 2.87766431 |
156 | regulation of histone H3-K27 methylation (GO:0061085) | 2.87111919 |
157 | keratinocyte development (GO:0003334) | 2.86386619 |
158 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.86368485 |
159 | response to thyroid hormone (GO:0097066) | 2.86077867 |
160 | superoxide anion generation (GO:0042554) | 2.85942223 |
161 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.85734641 |
162 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.85583771 |
163 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.85475522 |
164 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.85475522 |
165 | positive regulation of interferon-alpha production (GO:0032727) | 2.84701557 |
166 | cell cycle G1/S phase transition (GO:0044843) | 2.84337975 |
167 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.84337975 |
168 | protein K6-linked ubiquitination (GO:0085020) | 2.83866239 |
169 | telomere maintenance via telomere lengthening (GO:0010833) | 2.83503890 |
170 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.83382119 |
171 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.83064439 |
172 | translational elongation (GO:0006414) | 2.82983590 |
173 | negative regulation of interleukin-17 production (GO:0032700) | 2.82138696 |
174 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.81367710 |
175 | myeloid dendritic cell differentiation (GO:0043011) | 2.81292541 |
176 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.80624585 |
177 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.80567343 |
178 | regulation of regulated secretory pathway (GO:1903305) | 2.80463326 |
179 | regulation of T cell tolerance induction (GO:0002664) | 2.80139549 |
180 | regulation of antigen processing and presentation (GO:0002577) | 2.78848823 |
181 | neutrophil chemotaxis (GO:0030593) | 2.78566549 |
182 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.78209932 |
183 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.78209932 |
184 | phagosome maturation (GO:0090382) | 2.78082537 |
185 | protein localization to kinetochore (GO:0034501) | 2.77814888 |
186 | DNA-templated transcription, termination (GO:0006353) | 2.76900208 |
187 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.76733557 |
188 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.76502382 |
189 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.75568118 |
190 | cellular response to type I interferon (GO:0071357) | 2.75352638 |
191 | type I interferon signaling pathway (GO:0060337) | 2.75352638 |
192 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.75021624 |
193 | neutrophil mediated immunity (GO:0002446) | 2.74811006 |
194 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.73696948 |
195 | defense response to protozoan (GO:0042832) | 2.73676818 |
196 | myeloid dendritic cell activation (GO:0001773) | 2.72161164 |
197 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.71875977 |
198 | response to type I interferon (GO:0034340) | 2.71665945 |
199 | neutrophil migration (GO:1990266) | 2.71461320 |
200 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.71038276 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.35989324 |
2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.56866991 |
3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.44280038 |
4 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.85023367 |
5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.21206902 |
6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.98488129 |
7 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.88494919 |
8 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.85345797 |
9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.60574320 |
10 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.52817181 |
11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.49202276 |
12 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.45637110 |
13 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.40640043 |
14 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.36842725 |
15 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.31327008 |
16 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.25390941 |
17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.18413835 |
18 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.16894057 |
19 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.10512317 |
20 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.08861480 |
21 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.05517726 |
22 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.98485780 |
23 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.83018915 |
24 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.81878026 |
25 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.76384600 |
26 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.75530679 |
27 | SPI1_23127762_ChIP-Seq_K562_Human | 2.74138831 |
28 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.72449611 |
29 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.64152596 |
30 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.63679793 |
31 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.55399233 |
32 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.52330976 |
33 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.48141339 |
34 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.46880355 |
35 | * CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.42329100 |
36 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.40432876 |
37 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.40267439 |
38 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.37785135 |
39 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.36228610 |
40 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.35628130 |
41 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.33595704 |
42 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.29578880 |
43 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.28078124 |
44 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.23355862 |
45 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.22379732 |
46 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.16246242 |
47 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.12047218 |
48 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 2.10471265 |
49 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.09513257 |
50 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.02214177 |
51 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.02141133 |
52 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.01127687 |
53 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.00247856 |
54 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.96640624 |
55 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.95396757 |
56 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.94235419 |
57 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.93964566 |
58 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.91543637 |
59 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.87919137 |
60 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86838184 |
61 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.84732190 |
62 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.79323221 |
63 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.78188036 |
64 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.77994379 |
65 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.76970776 |
66 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.75497223 |
67 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.74665329 |
68 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.74596811 |
69 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.73326657 |
70 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.71963411 |
71 | * MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.69925091 |
72 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.69855681 |
73 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.69820585 |
74 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.69291953 |
75 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.68544054 |
76 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.68156309 |
77 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.68082782 |
78 | MYB_26560356_Chip-Seq_TH2_Human | 1.67392073 |
79 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.66656205 |
80 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.65492265 |
81 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.63974785 |
82 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.61369684 |
83 | GATA1_19941826_ChIP-Seq_K562_Human | 1.61352713 |
84 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.59188230 |
85 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.58774921 |
86 | * MAF_26560356_Chip-Seq_TH1_Human | 1.58322909 |
87 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.57018133 |
88 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.56725580 |
89 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.54328301 |
90 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.47102978 |
91 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.44454515 |
92 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.43935310 |
93 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.42496796 |
94 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.40489121 |
95 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.38093921 |
96 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.37528508 |
97 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.36284554 |
98 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36257650 |
99 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.35904496 |
100 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.35781167 |
101 | GATA1_22025678_ChIP-Seq_K562_Human | 1.34902735 |
102 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.34757170 |
103 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.32820119 |
104 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32502078 |
105 | MYB_26560356_Chip-Seq_TH1_Human | 1.32127009 |
106 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.31955715 |
107 | UTX_26944678_Chip-Seq_JUKART_Human | 1.31656977 |
108 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31040916 |
109 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.30931690 |
110 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.30730633 |
111 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.30323818 |
112 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.29798364 |
113 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.28156463 |
114 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.28057177 |
115 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.27247042 |
116 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.27120834 |
117 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.26291046 |
118 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25898149 |
119 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.24203739 |
120 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23769485 |
121 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.23667561 |
122 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.23311135 |
123 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.21621963 |
124 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.21501042 |
125 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.21182751 |
126 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20616885 |
127 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.17455058 |
128 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.17216684 |
129 | GATA3_26560356_Chip-Seq_TH2_Human | 1.15697618 |
130 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.14668930 |
131 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.14453925 |
132 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.14133397 |
133 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.12312618 |
134 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.11592219 |
135 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.10202310 |
136 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.09037091 |
137 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.08229439 |
138 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.06660316 |
139 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.05069838 |
140 | * MAF_26560356_Chip-Seq_TH2_Human | 1.01570423 |
141 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01317322 |
142 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.01098405 |
143 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.00250355 |
144 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.00017223 |
145 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.99528693 |
146 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.99313313 |
147 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.97823810 |
148 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.96882983 |
149 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.96810004 |
150 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.95974890 |
151 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.95670067 |
152 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.95188183 |
153 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.94858303 |
154 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.94554525 |
155 | MYC_22102868_ChIP-Seq_BL_Human | 0.94469795 |
156 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.94274166 |
157 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93560385 |
158 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.92246561 |
159 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.89848149 |
160 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.89733536 |
161 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.89401476 |
162 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.88026368 |
163 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.87741367 |
164 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.86455360 |
165 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.85446109 |
166 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.85213343 |
167 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.85213343 |
168 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.85213343 |
169 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.85183249 |
170 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.84494232 |
171 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.84460170 |
172 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.84400989 |
173 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.83749969 |
174 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.83462277 |
175 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.83353090 |
176 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.82693048 |
177 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.82226803 |
178 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.81844782 |
179 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.81740390 |
180 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.81316447 |
181 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.81173743 |
182 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.79947669 |
183 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.79614900 |
184 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.78607692 |
185 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.76461255 |
186 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.76334258 |
187 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.76112092 |
188 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.75562967 |
189 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.75351844 |
190 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.73517296 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003693_abnormal_embryo_hatching | 5.94243373 |
2 | MP0003111_abnormal_nucleus_morphology | 4.48893000 |
3 | MP0003303_peritoneal_inflammation | 4.17761108 |
4 | MP0003724_increased_susceptibility_to | 4.04483830 |
5 | MP0010094_abnormal_chromosome_stability | 3.84434386 |
6 | MP0004957_abnormal_blastocyst_morpholog | 3.54260630 |
7 | MP0008057_abnormal_DNA_replication | 3.50595465 |
8 | MP0003436_decreased_susceptibility_to | 3.43035902 |
9 | MP0008058_abnormal_DNA_repair | 3.42899690 |
10 | MP0006082_CNS_inflammation | 3.41907651 |
11 | MP0003718_maternal_effect | 3.32072879 |
12 | MP0003077_abnormal_cell_cycle | 3.23066913 |
13 | MP0008260_abnormal_autophagy | 3.17452903 |
14 | MP0002419_abnormal_innate_immunity | 3.02742317 |
15 | MP0003172_abnormal_lysosome_physiology | 2.90999178 |
16 | MP0009785_altered_susceptibility_to | 2.80839902 |
17 | MP0003941_abnormal_skin_development | 2.77592917 |
18 | MP0002396_abnormal_hematopoietic_system | 2.74605681 |
19 | MP0008007_abnormal_cellular_replicative | 2.69962538 |
20 | MP0003786_premature_aging | 2.67535506 |
21 | MP0003191_abnormal_cellular_cholesterol | 2.65543862 |
22 | MP0005000_abnormal_immune_tolerance | 2.55370345 |
23 | MP0005025_abnormal_response_to | 2.55338218 |
24 | MP0005387_immune_system_phenotype | 2.49966110 |
25 | MP0001790_abnormal_immune_system | 2.49966110 |
26 | MP0000685_abnormal_immune_system | 2.32221709 |
27 | MP0003300_gastrointestinal_ulcer | 2.32146792 |
28 | MP0002452_abnormal_antigen_presenting | 2.29383874 |
29 | MP0002723_abnormal_immune_serum | 2.21653131 |
30 | MP0001800_abnormal_humoral_immune | 2.21043029 |
31 | MP0000343_altered_response_to | 2.18014827 |
32 | MP0003136_yellow_coat_color | 2.17517342 |
33 | MP0000604_amyloidosis | 2.13985181 |
34 | MP0001533_abnormal_skeleton_physiology | 2.07082773 |
35 | MP0003315_abnormal_perineum_morphology | 2.05215645 |
36 | MP0008932_abnormal_embryonic_tissue | 2.02904847 |
37 | MP0006292_abnormal_olfactory_placode | 2.00966053 |
38 | MP0002420_abnormal_adaptive_immunity | 1.98999905 |
39 | MP0009764_decreased_sensitivity_to | 1.98220112 |
40 | MP0001819_abnormal_immune_cell | 1.98086965 |
41 | MP0003075_altered_response_to | 1.95574685 |
42 | MP0005377_hearing/vestibular/ear_phenot | 1.95525995 |
43 | MP0003878_abnormal_ear_physiology | 1.95525995 |
44 | MP0003690_abnormal_glial_cell | 1.83585621 |
45 | MP0009278_abnormal_bone_marrow | 1.81036202 |
46 | MP0002132_abnormal_respiratory_system | 1.78752679 |
47 | MP0004510_myositis | 1.78296392 |
48 | MP0002405_respiratory_system_inflammati | 1.76986529 |
49 | MP0001845_abnormal_inflammatory_respons | 1.76261959 |
50 | MP0009840_abnormal_foam_cell | 1.76127182 |
51 | MP0008877_abnormal_DNA_methylation | 1.71770602 |
52 | MP0002998_abnormal_bone_remodeling | 1.69350211 |
53 | MP0000490_abnormal_crypts_of | 1.68090371 |
54 | MP0002139_abnormal_hepatobiliary_system | 1.66864442 |
55 | MP0005310_abnormal_salivary_gland | 1.66427356 |
56 | MP0002277_abnormal_respiratory_mucosa | 1.63799932 |
57 | MP0009333_abnormal_splenocyte_physiolog | 1.61788208 |
58 | MP0003656_abnormal_erythrocyte_physiolo | 1.57509383 |
59 | MP0008469_abnormal_protein_level | 1.56000047 |
60 | MP0008004_abnormal_stomach_pH | 1.53058572 |
61 | MP0005167_abnormal_blood-brain_barrier | 1.51468064 |
62 | MP0004947_skin_inflammation | 1.51445329 |
63 | MP0010155_abnormal_intestine_physiology | 1.51329934 |
64 | MP0004019_abnormal_vitamin_homeostasis | 1.50108828 |
65 | MP0004381_abnormal_hair_follicle | 1.46558065 |
66 | MP0000383_abnormal_hair_follicle | 1.43813484 |
67 | MP0005058_abnormal_lysosome_morphology | 1.42255623 |
68 | MP0002102_abnormal_ear_morphology | 1.41461124 |
69 | MP0000716_abnormal_immune_system | 1.40794733 |
70 | MP0000858_altered_metastatic_potential | 1.37272018 |
71 | MP0000465_gastrointestinal_hemorrhage | 1.35445943 |
72 | MP0004808_abnormal_hematopoietic_stem | 1.35393366 |
73 | MP0000350_abnormal_cell_proliferation | 1.35291822 |
74 | MP0001730_embryonic_growth_arrest | 1.31749939 |
75 | MP0003938_abnormal_ear_development | 1.30356536 |
76 | MP0002210_abnormal_sex_determination | 1.28661390 |
77 | MP0008995_early_reproductive_senescence | 1.27801354 |
78 | MP0003448_altered_tumor_morphology | 1.27800276 |
79 | MP0000566_synostosis | 1.27649314 |
80 | MP0004883_abnormal_blood_vessel | 1.25138259 |
81 | MP0003183_abnormal_peptide_metabolism | 1.24929195 |
82 | MP0003806_abnormal_nucleotide_metabolis | 1.22659163 |
83 | MP0002796_impaired_skin_barrier | 1.21036981 |
84 | MP0010307_abnormal_tumor_latency | 1.20325882 |
85 | MP0001545_abnormal_hematopoietic_system | 1.19962388 |
86 | MP0005397_hematopoietic_system_phenotyp | 1.19962388 |
87 | MP0005075_abnormal_melanosome_morpholog | 1.19598865 |
88 | MP0003123_paternal_imprinting | 1.16016365 |
89 | MP0001188_hyperpigmentation | 1.13879482 |
90 | MP0005164_abnormal_response_to | 1.13817495 |
91 | MP0005166_decreased_susceptibility_to | 1.13286310 |
92 | MP0001145_abnormal_male_reproductive | 1.11672163 |
93 | MP0001542_abnormal_bone_strength | 1.11030611 |
94 | MP0003186_abnormal_redox_activity | 1.10003278 |
95 | MP0002095_abnormal_skin_pigmentation | 1.09834429 |
96 | MP0005451_abnormal_body_composition | 1.09801027 |
97 | MP0003567_abnormal_fetal_cardiomyocyte | 1.09338764 |
98 | MP0002254_reproductive_system_inflammat | 1.05009006 |
99 | MP0006054_spinal_hemorrhage | 1.04811867 |
100 | MP0001672_abnormal_embryogenesis/_devel | 1.03962764 |
101 | MP0005380_embryogenesis_phenotype | 1.03962764 |
102 | MP0000313_abnormal_cell_death | 1.03911727 |
103 | MP0001929_abnormal_gametogenesis | 1.03100130 |
104 | MP0005395_other_phenotype | 1.02810732 |
105 | MP0000920_abnormal_myelination | 1.02217566 |
106 | MP0000015_abnormal_ear_pigmentation | 0.99473138 |
107 | MP0000653_abnormal_sex_gland | 0.99205850 |
108 | MP0000647_abnormal_sebaceous_gland | 0.97894113 |
109 | MP0003329_amyloid_beta_deposits | 0.97536196 |
110 | MP0003453_abnormal_keratinocyte_physiol | 0.96840661 |
111 | MP0009763_increased_sensitivity_to | 0.95849183 |
112 | MP0005501_abnormal_skin_physiology | 0.95041769 |
113 | MP0001119_abnormal_female_reproductive | 0.94302203 |
114 | MP0004147_increased_porphyrin_level | 0.92729725 |
115 | MP0002080_prenatal_lethality | 0.92393014 |
116 | MP0001851_eye_inflammation | 0.90496024 |
117 | MP0005671_abnormal_response_to | 0.89262590 |
118 | MP0002019_abnormal_tumor_incidence | 0.87493922 |
119 | MP0000569_abnormal_digit_pigmentation | 0.87113434 |
120 | MP0002160_abnormal_reproductive_system | 0.87059826 |
121 | MP0001853_heart_inflammation | 0.86145734 |
122 | MP0003195_calcinosis | 0.85909623 |
123 | MP0002098_abnormal_vibrissa_morphology | 0.85633494 |
124 | MP0002722_abnormal_immune_system | 0.85510357 |
125 | MP0005389_reproductive_system_phenotype | 0.84494930 |
126 | MP0002148_abnormal_hypersensitivity_rea | 0.84266880 |
127 | MP0001216_abnormal_epidermal_layer | 0.83992032 |
128 | MP0001697_abnormal_embryo_size | 0.81866337 |
129 | MP0005365_abnormal_bile_salt | 0.81178448 |
130 | MP0003984_embryonic_growth_retardation | 0.80743187 |
131 | MP0001986_abnormal_taste_sensitivity | 0.79616071 |
132 | MP0000689_abnormal_spleen_morphology | 0.79543255 |
133 | MP0002938_white_spotting | 0.79474631 |
134 | MP0009379_abnormal_foot_pigmentation | 0.78852622 |
135 | MP0005174_abnormal_tail_pigmentation | 0.78661640 |
136 | MP0002088_abnormal_embryonic_growth/wei | 0.78002417 |
137 | MP0005390_skeleton_phenotype | 0.77786842 |
138 | MP0003795_abnormal_bone_structure | 0.77321950 |
139 | MP0001663_abnormal_digestive_system | 0.76701818 |
140 | MP0003763_abnormal_thymus_physiology | 0.76697985 |
141 | MP0002138_abnormal_hepatobiliary_system | 0.76684816 |
142 | MP0002085_abnormal_embryonic_tissue | 0.76530576 |
143 | MP0001835_abnormal_antigen_presentation | 0.76005735 |
144 | MP0002086_abnormal_extraembryonic_tissu | 0.70861535 |
145 | MP0003866_abnormal_defecation | 0.70620808 |
146 | MP0005464_abnormal_platelet_physiology | 0.70471856 |
147 | MP0000371_diluted_coat_color | 0.70324552 |
148 | MP0002638_abnormal_pupillary_reflex | 0.69944084 |
149 | MP0000249_abnormal_blood_vessel | 0.69370341 |
150 | MP0001661_extended_life_span | 0.68975745 |
151 | MP0002697_abnormal_eye_size | 0.68750881 |
152 | MP0002332_abnormal_exercise_endurance | 0.68665885 |
153 | MP0008874_decreased_physiological_sensi | 0.68252152 |
154 | MP0003828_pulmonary_edema | 0.68066059 |
155 | MP0009765_abnormal_xenobiotic_induced | 0.66284636 |
156 | MP0002877_abnormal_melanocyte_morpholog | 0.65326331 |
157 | MP0001293_anophthalmia | 0.65147077 |
158 | MP0004264_abnormal_extraembryonic_tissu | 0.63942771 |
159 | MP0009697_abnormal_copulation | 0.63426699 |
160 | MP0000627_abnormal_mammary_gland | 0.63065933 |
161 | MP0002398_abnormal_bone_marrow | 0.62752314 |
162 | MP0003699_abnormal_female_reproductive | 0.62480345 |
163 | MP0002429_abnormal_blood_cell | 0.61813966 |
164 | MP0001286_abnormal_eye_development | 0.61239981 |
165 | MP0002092_abnormal_eye_morphology | 0.60958486 |
166 | MP0010678_abnormal_skin_adnexa | 0.59991348 |
167 | MP0005621_abnormal_cell_physiology | 0.59984515 |
168 | MP0005165_increased_susceptibility_to | 0.59534976 |
169 | MP0005319_abnormal_enzyme/_coenzyme | 0.58765459 |
170 | MP0000609_abnormal_liver_physiology | 0.58652191 |
171 | MP0000703_abnormal_thymus_morphology | 0.56524089 |
172 | MP0005647_abnormal_sex_gland | 0.54184192 |
173 | MP0003091_abnormal_cell_migration | 0.53205839 |
174 | MP0002090_abnormal_vision | 0.52865063 |
175 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.51870993 |
176 | MP0003633_abnormal_nervous_system | 0.51704476 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of glycolipid metabolism (HP:0010969) | 6.96939665 |
2 | Abnormality of liposaccharide metabolism (HP:0010968) | 6.96939665 |
3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 6.96939665 |
4 | Abnormality of macrophages (HP:0004311) | 5.50057015 |
5 | Recurrent bacterial skin infections (HP:0005406) | 5.40646773 |
6 | Recurrent abscess formation (HP:0002722) | 5.36472254 |
7 | Eczematoid dermatitis (HP:0000976) | 5.34902404 |
8 | Increased cerebral lipofuscin (HP:0011813) | 5.04007560 |
9 | Birth length less than 3rd percentile (HP:0003561) | 4.97706637 |
10 | Breast hypoplasia (HP:0003187) | 4.52034585 |
11 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.46715480 |
12 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 4.38684473 |
13 | Systemic lupus erythematosus (HP:0002725) | 4.34394155 |
14 | Dysostosis multiplex (HP:0000943) | 4.23109910 |
15 | Disinhibition (HP:0000734) | 4.21348450 |
16 | Chromsome breakage (HP:0040012) | 4.10164936 |
17 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.09506779 |
18 | Reticulocytopenia (HP:0001896) | 4.07673786 |
19 | Orchitis (HP:0100796) | 4.04099318 |
20 | Myositis (HP:0100614) | 3.99654890 |
21 | Loss of speech (HP:0002371) | 3.94963202 |
22 | Retrobulbar optic neuritis (HP:0100654) | 3.89248693 |
23 | Optic neuritis (HP:0100653) | 3.89248693 |
24 | Rough bone trabeculation (HP:0100670) | 3.83954513 |
25 | Stomatitis (HP:0010280) | 3.78956778 |
26 | Spontaneous hematomas (HP:0007420) | 3.71402831 |
27 | Mediastinal lymphadenopathy (HP:0100721) | 3.67331100 |
28 | Impulsivity (HP:0100710) | 3.60232706 |
29 | Mutism (HP:0002300) | 3.43833634 |
30 | Obstructive lung disease (HP:0006536) | 3.35854469 |
31 | Chronic obstructive pulmonary disease (HP:0006510) | 3.35854469 |
32 | Carpal bone hypoplasia (HP:0001498) | 3.35809379 |
33 | Abnormality of the preputium (HP:0100587) | 3.32968894 |
34 | Purpura (HP:0000979) | 3.26990438 |
35 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.25180984 |
36 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.25180984 |
37 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.25180984 |
38 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.21271583 |
39 | Recurrent skin infections (HP:0001581) | 3.20996884 |
40 | Macrocytic anemia (HP:0001972) | 3.14871233 |
41 | Autoimmune thrombocytopenia (HP:0001973) | 3.13938188 |
42 | Abnormal number of erythroid precursors (HP:0012131) | 3.11666963 |
43 | Meckel diverticulum (HP:0002245) | 3.09726068 |
44 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.07599271 |
45 | Mucopolysacchariduria (HP:0008155) | 3.07599271 |
46 | Patellar aplasia (HP:0006443) | 3.02420458 |
47 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.02256893 |
48 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.01345232 |
49 | Abnormal trabecular bone morphology (HP:0100671) | 3.01281970 |
50 | Oral leukoplakia (HP:0002745) | 2.95911109 |
51 | Gingivitis (HP:0000230) | 2.95482380 |
52 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.94816980 |
53 | Recurrent fungal infections (HP:0002841) | 2.91082652 |
54 | Abnormality of the ileum (HP:0001549) | 2.89616231 |
55 | Ureteral duplication (HP:0000073) | 2.88615364 |
56 | Petechiae (HP:0000967) | 2.87116429 |
57 | Prostate neoplasm (HP:0100787) | 2.86273451 |
58 | Glomerulonephritis (HP:0000099) | 2.84975460 |
59 | Bone marrow hypocellularity (HP:0005528) | 2.84716886 |
60 | Aplastic anemia (HP:0001915) | 2.82806190 |
61 | Abnormality of chromosome stability (HP:0003220) | 2.81997984 |
62 | Keratoconjunctivitis sicca (HP:0001097) | 2.78343702 |
63 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.76683304 |
64 | Abnormal spermatogenesis (HP:0008669) | 2.76300364 |
65 | Myocardial infarction (HP:0001658) | 2.76035391 |
66 | Megaloblastic anemia (HP:0001889) | 2.73504685 |
67 | Neurofibrillary tangles (HP:0002185) | 2.73294938 |
68 | Entropion (HP:0000621) | 2.73087656 |
69 | Sparse eyelashes (HP:0000653) | 2.69394680 |
70 | Congenital, generalized hypertrichosis (HP:0004540) | 2.68920777 |
71 | Axonal loss (HP:0003447) | 2.68652047 |
72 | Hyperglycinuria (HP:0003108) | 2.66937284 |
73 | Agnosia (HP:0010524) | 2.66604974 |
74 | Cerebral hypomyelination (HP:0006808) | 2.66399515 |
75 | Hyperglycinemia (HP:0002154) | 2.64686806 |
76 | Meningitis (HP:0001287) | 2.61298168 |
77 | Hepatosplenomegaly (HP:0001433) | 2.60235278 |
78 | Prolonged bleeding time (HP:0003010) | 2.59120963 |
79 | Urticaria (HP:0001025) | 2.58610806 |
80 | Keratoconjunctivitis (HP:0001096) | 2.54810921 |
81 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.54213543 |
82 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.53773252 |
83 | Increased serum ferritin (HP:0003281) | 2.53327245 |
84 | Pulmonary infiltrates (HP:0002113) | 2.52751999 |
85 | Amyloidosis (HP:0011034) | 2.52668645 |
86 | T lymphocytopenia (HP:0005403) | 2.48607391 |
87 | Hematochezia (HP:0002573) | 2.48160907 |
88 | Epistaxis (HP:0000421) | 2.46773255 |
89 | Gingival bleeding (HP:0000225) | 2.45888460 |
90 | Hemoptysis (HP:0002105) | 2.44500342 |
91 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.43325479 |
92 | Encephalitis (HP:0002383) | 2.41363934 |
93 | Vasculitis (HP:0002633) | 2.41147982 |
94 | Upper motor neuron abnormality (HP:0002127) | 2.39984305 |
95 | Prolonged neonatal jaundice (HP:0006579) | 2.38503796 |
96 | Triphalangeal thumb (HP:0001199) | 2.37844617 |
97 | Recurrent cutaneous fungal infections (HP:0011370) | 2.36949978 |
98 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.36949978 |
99 | Inappropriate behavior (HP:0000719) | 2.36233543 |
100 | Abnormality of the umbilical cord (HP:0010881) | 2.35900865 |
101 | Gastrointestinal infarctions (HP:0005244) | 2.35552500 |
102 | Absent radius (HP:0003974) | 2.35403934 |
103 | Abnormality of secondary sexual hair (HP:0009888) | 2.34453937 |
104 | Abnormality of the axillary hair (HP:0100134) | 2.34453937 |
105 | Neuronal loss in central nervous system (HP:0002529) | 2.29902573 |
106 | Pallor (HP:0000980) | 2.29709509 |
107 | Aplasia involving forearm bones (HP:0009822) | 2.29329366 |
108 | Absent forearm bone (HP:0003953) | 2.29329366 |
109 | Duplicated collecting system (HP:0000081) | 2.28978139 |
110 | Abnormality of T cell number (HP:0011839) | 2.27455322 |
111 | Abnormality of iron homeostasis (HP:0011031) | 2.27197593 |
112 | Duodenal stenosis (HP:0100867) | 2.26787411 |
113 | Small intestinal stenosis (HP:0012848) | 2.26787411 |
114 | Secondary amenorrhea (HP:0000869) | 2.26411140 |
115 | Abnormality of the anterior horn cell (HP:0006802) | 2.25746782 |
116 | Degeneration of anterior horn cells (HP:0002398) | 2.25746782 |
117 | Progressive neurologic deterioration (HP:0002344) | 2.25568679 |
118 | Pustule (HP:0200039) | 2.21533747 |
119 | Myelodysplasia (HP:0002863) | 2.20445514 |
120 | Microretrognathia (HP:0000308) | 2.20255342 |
121 | Azoospermia (HP:0000027) | 2.19601340 |
122 | Horseshoe kidney (HP:0000085) | 2.17395814 |
123 | Absent thumb (HP:0009777) | 2.17305060 |
124 | Abnormality of the renal collecting system (HP:0004742) | 2.17240539 |
125 | Diminished motivation (HP:0000745) | 2.16737068 |
126 | Apathy (HP:0000741) | 2.16733392 |
127 | Type I transferrin isoform profile (HP:0003642) | 2.16547251 |
128 | Death in infancy (HP:0001522) | 2.16309944 |
129 | Polyneuropathy (HP:0001271) | 2.16107498 |
130 | Pulmonary embolism (HP:0002204) | 2.16093050 |
131 | Clubbing of toes (HP:0100760) | 2.14653971 |
132 | Premature ovarian failure (HP:0008209) | 2.13796411 |
133 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.13351041 |
134 | Complement deficiency (HP:0004431) | 2.13098086 |
135 | Recurrent viral infections (HP:0004429) | 2.11863583 |
136 | Arterial thrombosis (HP:0004420) | 2.11200324 |
137 | Split foot (HP:0001839) | 2.08411788 |
138 | Cerebral inclusion bodies (HP:0100314) | 2.08107741 |
139 | Premature graying of hair (HP:0002216) | 2.06219484 |
140 | Pathologic fracture (HP:0002756) | 2.05510085 |
141 | Conjunctival telangiectasia (HP:0000524) | 2.04108210 |
142 | Pancytopenia (HP:0001876) | 2.04100210 |
143 | Cellulitis (HP:0100658) | 2.03700414 |
144 | Leukocytosis (HP:0001974) | 2.02178305 |
145 | Zonular cataract (HP:0010920) | 2.02063595 |
146 | Anorexia (HP:0002039) | 1.97585683 |
147 | IgM deficiency (HP:0002850) | 1.97485004 |
148 | Reduced antithrombin III activity (HP:0001976) | 1.97344005 |
149 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 1.97231290 |
150 | Basal ganglia calcification (HP:0002135) | 1.96573131 |
151 | Osteomyelitis (HP:0002754) | 1.95830718 |
152 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.95544558 |
153 | Abnormality of glycine metabolism (HP:0010895) | 1.95544558 |
154 | Pancreatic fibrosis (HP:0100732) | 1.95203021 |
155 | Increased IgM level (HP:0003496) | 1.95076535 |
156 | Increased IgE level (HP:0003212) | 1.94848304 |
157 | Episodic fever (HP:0001954) | 1.94093233 |
158 | Capillary hemangiomas (HP:0005306) | 1.93823277 |
159 | Pancreatic cysts (HP:0001737) | 1.91654949 |
160 | Personality changes (HP:0000751) | 1.91185962 |
161 | Dementia (HP:0000726) | 1.90767136 |
162 | Chest pain (HP:0100749) | 1.90389755 |
163 | Peripheral demyelination (HP:0011096) | 1.90358578 |
164 | Gangrene (HP:0100758) | 1.89721260 |
165 | Short thumb (HP:0009778) | 1.89281008 |
166 | Nuclear cataract (HP:0100018) | 1.89121182 |
167 | Increased CSF protein (HP:0002922) | 1.88824658 |
168 | Vertigo (HP:0002321) | 1.88642385 |
169 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.88072471 |
170 | Microvesicular hepatic steatosis (HP:0001414) | 1.87935265 |
171 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.86651031 |
172 | Abnormality of serum amino acid levels (HP:0003112) | 1.86285834 |
173 | Memory impairment (HP:0002354) | 1.85471882 |
174 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.85437377 |
175 | Type 2 muscle fiber atrophy (HP:0003554) | 1.84801211 |
176 | Neoplasm of the pancreas (HP:0002894) | 1.83835921 |
177 | Hypoplasia of the radius (HP:0002984) | 1.82882137 |
178 | Muscle fiber atrophy (HP:0100295) | 1.80367712 |
179 | Abnormality of alanine metabolism (HP:0010916) | 1.80317620 |
180 | Hyperalaninemia (HP:0003348) | 1.80317620 |
181 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.80317620 |
182 | Tracheoesophageal fistula (HP:0002575) | 1.78053259 |
183 | CNS hypomyelination (HP:0003429) | 1.77229134 |
184 | Abnormality of DNA repair (HP:0003254) | 1.76411844 |
185 | Cellular immunodeficiency (HP:0005374) | 1.75194327 |
186 | Abnormality of the duodenum (HP:0002246) | 1.74962149 |
187 | Vacuolated lymphocytes (HP:0001922) | 1.73975291 |
188 | Aplasia/Hypoplasia of the earlobes (HP:0009906) | 1.72596006 |
189 | Stenosis of the external auditory canal (HP:0000402) | 1.72550435 |
190 | Multiple enchondromatosis (HP:0005701) | 1.72145020 |
191 | Abnormality of male internal genitalia (HP:0000022) | 1.71581250 |
192 | Irregular epiphyses (HP:0010582) | 1.71576050 |
193 | Stillbirth (HP:0003826) | 1.71572433 |
194 | Abnormality of the prostate (HP:0008775) | 1.71542333 |
195 | Abnormality of the labia minora (HP:0012880) | 1.71396765 |
196 | Absent hand (HP:0004050) | 1.71373323 |
Rank | Gene Set | Z-score |
---|---|---|
1 | WEE1 | 5.02823514 |
2 | BUB1 | 4.81151840 |
3 | RIPK4 | 4.27429537 |
4 | STK16 | 3.94383099 |
5 | EIF2AK1 | 3.40616544 |
6 | SRPK1 | 2.69645140 |
7 | CSK | 2.58699446 |
8 | PLK4 | 2.58289853 |
9 | IRAK3 | 2.55266168 |
10 | TSSK6 | 2.54750573 |
11 | MAP3K14 | 2.45412307 |
12 | FGR | 2.38916020 |
13 | MAP4K1 | 2.35324205 |
14 | NME2 | 2.34022091 |
15 | MKNK2 | 2.27269020 |
16 | ZAK | 2.22410570 |
17 | EIF2AK3 | 2.19568946 |
18 | BRSK2 | 2.15344941 |
19 | TTK | 2.11759817 |
20 | EPHA2 | 2.09440280 |
21 | ACVR1B | 2.02977863 |
22 | MKNK1 | 1.98984568 |
23 | ERN1 | 1.98360095 |
24 | DYRK3 | 1.96818317 |
25 | NEK2 | 1.93149493 |
26 | FES | 1.91737950 |
27 | ZAP70 | 1.91689361 |
28 | TBK1 | 1.87654618 |
29 | MAP3K11 | 1.87296741 |
30 | TAOK1 | 1.83475920 |
31 | PRPF4B | 1.79567048 |
32 | PIM2 | 1.77542592 |
33 | PLK1 | 1.77276035 |
34 | SYK | 1.65514460 |
35 | JAK3 | 1.64673407 |
36 | VRK1 | 1.63357633 |
37 | EIF2AK2 | 1.58882676 |
38 | CAMKK2 | 1.56265009 |
39 | PLK3 | 1.55029701 |
40 | IKBKE | 1.53449547 |
41 | TNK2 | 1.50539668 |
42 | CCNB1 | 1.47151510 |
43 | MAP3K13 | 1.46452963 |
44 | AKT3 | 1.45894590 |
45 | BTK | 1.39310861 |
46 | JAK2 | 1.36452845 |
47 | HCK | 1.36310452 |
48 | JAK1 | 1.27998812 |
49 | BLK | 1.26478665 |
50 | MAP3K1 | 1.26426204 |
51 | AURKB | 1.25072331 |
52 | TAOK3 | 1.24734931 |
53 | BMPR2 | 1.23147826 |
54 | CHEK2 | 1.20346883 |
55 | PDK2 | 1.19233504 |
56 | STK38L | 1.17484239 |
57 | BRSK1 | 1.16616213 |
58 | CDC7 | 1.16158239 |
59 | MARK3 | 1.15825053 |
60 | IRAK2 | 1.13853642 |
61 | CDK7 | 1.10095685 |
62 | RPS6KB2 | 1.05829138 |
63 | GRK6 | 1.04499245 |
64 | CAMK1D | 1.04421318 |
65 | NEK1 | 1.03233578 |
66 | ATR | 1.02773939 |
67 | DDR2 | 1.02445181 |
68 | AURKA | 1.01675165 |
69 | LCK | 0.97789834 |
70 | EPHB1 | 0.96618823 |
71 | PIM1 | 0.96475464 |
72 | RPS6KA4 | 0.92875437 |
73 | KSR2 | 0.91974681 |
74 | MAP3K5 | 0.90787973 |
75 | IRAK4 | 0.89464394 |
76 | CDC42BPA | 0.89324445 |
77 | SIK3 | 0.88505692 |
78 | TESK2 | 0.86432799 |
79 | CDK3 | 0.85430318 |
80 | STK4 | 0.84210234 |
81 | MAP3K3 | 0.84165553 |
82 | KIT | 0.82379503 |
83 | NUAK1 | 0.82248410 |
84 | PNCK | 0.82181976 |
85 | BRAF | 0.81787705 |
86 | NME1 | 0.80144956 |
87 | STK3 | 0.79868943 |
88 | TLK1 | 0.79859739 |
89 | MOS | 0.76798744 |
90 | PDK1 | 0.75949377 |
91 | PRKCI | 0.75937854 |
92 | PDPK1 | 0.75010816 |
93 | YES1 | 0.73391842 |
94 | STK24 | 0.73333686 |
95 | PINK1 | 0.72471753 |
96 | MST4 | 0.72405160 |
97 | ITK | 0.70828872 |
98 | DAPK2 | 0.70636110 |
99 | IKBKB | 0.66633491 |
100 | MAP3K2 | 0.64566673 |
101 | RIPK1 | 0.62642791 |
102 | CHEK1 | 0.60202193 |
103 | CSNK2A1 | 0.58083900 |
104 | MAP3K6 | 0.57697864 |
105 | EPHA3 | 0.57493288 |
106 | TIE1 | 0.57056846 |
107 | CDK4 | 0.56604752 |
108 | TEC | 0.56375149 |
109 | GRK1 | 0.54881904 |
110 | MAP3K8 | 0.54658068 |
111 | KSR1 | 0.54411587 |
112 | CDK8 | 0.54178846 |
113 | CDK6 | 0.51919525 |
114 | NEK9 | 0.51848452 |
115 | CSNK2A2 | 0.51828270 |
116 | FYN | 0.51155471 |
117 | ARAF | 0.50355811 |
118 | MARK2 | 0.49766600 |
119 | MAPK12 | 0.49723564 |
120 | ADRBK2 | 0.49256198 |
121 | BMPR1B | 0.49104743 |
122 | PDK3 | 0.48990095 |
123 | PDK4 | 0.48990095 |
124 | CAMK1G | 0.48828525 |
125 | TXK | 0.48199960 |
126 | DYRK2 | 0.47342770 |
127 | RPS6KA5 | 0.47153295 |
128 | SGK3 | 0.46641092 |
129 | BMX | 0.46524362 |
130 | TNIK | 0.45826597 |
131 | CHUK | 0.45158120 |
132 | CDK2 | 0.44922740 |
133 | TAOK2 | 0.44455240 |
134 | PIK3CG | 0.43861608 |
135 | NEK6 | 0.43543084 |
136 | TGFBR1 | 0.43199497 |
137 | CAMKK1 | 0.42808408 |
138 | ABL2 | 0.41894378 |
139 | RPS6KC1 | 0.41876336 |
140 | RPS6KL1 | 0.41876336 |
141 | ABL1 | 0.40978997 |
142 | CSF1R | 0.40408461 |
143 | MAPK7 | 0.38087737 |
144 | PAK1 | 0.37211691 |
145 | TYK2 | 0.36775160 |
146 | MAP2K3 | 0.36484499 |
147 | KDR | 0.34831996 |
148 | TGFBR2 | 0.34375198 |
149 | CDK1 | 0.34076787 |
150 | RPS6KA6 | 0.33809815 |
151 | STK10 | 0.33799814 |
152 | ATM | 0.33792243 |
153 | MAP2K6 | 0.33261292 |
154 | MAP2K2 | 0.33094763 |
155 | GRK7 | 0.32955199 |
156 | LYN | 0.32409902 |
157 | PRKCQ | 0.32337306 |
158 | PASK | 0.30002978 |
159 | SGK2 | 0.29640726 |
160 | MAPKAPK2 | 0.29413268 |
161 | WNK3 | 0.28438108 |
162 | BCKDK | 0.28415351 |
163 | MAPKAPK3 | 0.28340455 |
164 | PTK2B | 0.28063693 |
165 | PAK4 | 0.27935646 |
166 | PRKCD | 0.27782019 |
167 | IRAK1 | 0.27357239 |
168 | FGFR3 | 0.26804220 |
169 | MAP2K4 | 0.26280452 |
170 | RPS6KA2 | 0.26096482 |
171 | MATK | 0.25694654 |
172 | PRKG2 | 0.25038748 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RNA polymerase_Homo sapiens_hsa03020 | 4.55748623 |
2 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 4.22116094 |
3 | Proteasome_Homo sapiens_hsa03050 | 3.78538698 |
4 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.76469644 |
5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.58873545 |
6 | Ribosome_Homo sapiens_hsa03010 | 3.58226091 |
7 | DNA replication_Homo sapiens_hsa03030 | 3.40614139 |
8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 3.03391540 |
9 | Leishmaniasis_Homo sapiens_hsa05140 | 2.90670921 |
10 | Mismatch repair_Homo sapiens_hsa03430 | 2.85942103 |
11 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.73471297 |
12 | Homologous recombination_Homo sapiens_hsa03440 | 2.70695038 |
13 | RNA transport_Homo sapiens_hsa03013 | 2.64301257 |
14 | Spliceosome_Homo sapiens_hsa03040 | 2.57885069 |
15 | Basal transcription factors_Homo sapiens_hsa03022 | 2.44558973 |
16 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.44048104 |
17 | Tuberculosis_Homo sapiens_hsa05152 | 2.40640270 |
18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.39070696 |
19 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.34007321 |
20 | Allograft rejection_Homo sapiens_hsa05330 | 2.30585005 |
21 | Cell cycle_Homo sapiens_hsa04110 | 2.21874531 |
22 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.17316652 |
23 | Base excision repair_Homo sapiens_hsa03410 | 2.15947814 |
24 | Malaria_Homo sapiens_hsa05144 | 2.13234678 |
25 | Phagosome_Homo sapiens_hsa04145 | 2.02025315 |
26 | Regulation of autophagy_Homo sapiens_hsa04140 | 2.02009306 |
27 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.00604925 |
28 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.89665152 |
29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.78462194 |
30 | Purine metabolism_Homo sapiens_hsa00230 | 1.75048232 |
31 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.72525692 |
32 | Pertussis_Homo sapiens_hsa05133 | 1.71331149 |
33 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.66228019 |
34 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.60339169 |
35 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.59725859 |
36 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.59548922 |
37 | * Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.58618302 |
38 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.58473459 |
39 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.51417401 |
40 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.45045306 |
41 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.45016953 |
42 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.40714106 |
43 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.39703235 |
44 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.38899850 |
45 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.36907288 |
46 | Salmonella infection_Homo sapiens_hsa05132 | 1.34671102 |
47 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.32291803 |
48 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.29682480 |
49 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.28523557 |
50 | RNA degradation_Homo sapiens_hsa03018 | 1.27368871 |
51 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.24623399 |
52 | Viral myocarditis_Homo sapiens_hsa05416 | 1.18347364 |
53 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.17612072 |
54 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.17041926 |
55 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.13822595 |
56 | Other glycan degradation_Homo sapiens_hsa00511 | 1.09063009 |
57 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.06024175 |
58 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.04963277 |
59 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.03997904 |
60 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.00347227 |
61 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.00174523 |
62 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.00007132 |
63 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.99933165 |
64 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.99575708 |
65 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.97491349 |
66 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.97268811 |
67 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.96905965 |
68 | Platelet activation_Homo sapiens_hsa04611 | 0.94481492 |
69 | Shigellosis_Homo sapiens_hsa05131 | 0.89188756 |
70 | Hepatitis C_Homo sapiens_hsa05160 | 0.88005923 |
71 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.85345205 |
72 | Hepatitis B_Homo sapiens_hsa05161 | 0.85317731 |
73 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.84628589 |
74 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.83864921 |
75 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.79211252 |
76 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.76750858 |
77 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.76635829 |
78 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.76354988 |
79 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.75025597 |
80 | Amoebiasis_Homo sapiens_hsa05146 | 0.72252602 |
81 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.70285512 |
82 | Prion diseases_Homo sapiens_hsa05020 | 0.70215257 |
83 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.69724021 |
84 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.69539889 |
85 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.67294378 |
86 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.66865068 |
87 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.65430223 |
88 | Lysosome_Homo sapiens_hsa04142 | 0.64001695 |
89 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.62657421 |
90 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.61202214 |
91 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.59993445 |
92 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.59599610 |
93 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.59052060 |
94 | Endocytosis_Homo sapiens_hsa04144 | 0.58846622 |
95 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.58032223 |
96 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.57073725 |
97 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56759740 |
98 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.55388307 |
99 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.54898288 |
100 | Mineral absorption_Homo sapiens_hsa04978 | 0.53486632 |
101 | Metabolic pathways_Homo sapiens_hsa01100 | 0.53473458 |
102 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.53355782 |
103 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.51456767 |
104 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.51230892 |
105 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.50311027 |
106 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.48617193 |
107 | Bladder cancer_Homo sapiens_hsa05219 | 0.47655898 |
108 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.46752267 |
109 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.46111656 |
110 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.45699490 |
111 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.45089192 |
112 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.43487920 |
113 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.42311129 |
114 | Sulfur relay system_Homo sapiens_hsa04122 | 0.41897368 |
115 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.41753491 |
116 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.40794691 |
117 | Protein export_Homo sapiens_hsa03060 | 0.40649653 |
118 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.40382612 |
119 | Huntingtons disease_Homo sapiens_hsa05016 | 0.40359472 |
120 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.40124810 |
121 | Galactose metabolism_Homo sapiens_hsa00052 | 0.39804239 |
122 | Legionellosis_Homo sapiens_hsa05134 | 0.38868546 |
123 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.38613217 |
124 | Circadian rhythm_Homo sapiens_hsa04710 | 0.36824367 |
125 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.36777623 |
126 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.36541742 |
127 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.35932616 |
128 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.35821140 |
129 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.35778118 |
130 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.35426015 |
131 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.34652786 |
132 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.33517690 |
133 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.32160253 |
134 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.32117549 |
135 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.30486297 |
136 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.30359765 |
137 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.29938346 |
138 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.29328138 |
139 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.28359746 |
140 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.27375957 |
141 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.26442529 |
142 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.25162551 |
143 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.24884985 |
144 | Retinol metabolism_Homo sapiens_hsa00830 | 0.24795710 |
145 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.24134427 |
146 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.24011628 |
147 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.23459912 |
148 | Apoptosis_Homo sapiens_hsa04210 | 0.23452539 |
149 | Measles_Homo sapiens_hsa05162 | 0.23113104 |
150 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.22989250 |
151 | Influenza A_Homo sapiens_hsa05164 | 0.21145300 |
152 | HTLV-I infection_Homo sapiens_hsa05166 | 0.20854041 |
153 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.20319813 |
154 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.19456683 |
155 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.18351612 |
156 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.17659237 |
157 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.16412297 |
158 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.16105471 |
159 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.14551296 |
160 | Phototransduction_Homo sapiens_hsa04744 | 0.12385144 |
161 | Asthma_Homo sapiens_hsa05310 | 0.12111937 |
162 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.08976410 |
163 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.08338529 |
164 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.07127524 |